全球基因編輯市場規模、佔有率、趨勢和成長分析報告（2026-2034）

基因編輯市場預計將從 2025 年的 78 億美元成長到 2034 年的 295.1 億美元，2026 年至 2034 年的複合年成長率為 15.93%。

全球基因編輯市場正經歷快速成長，這主要得益於基因工程技術的進步和精準醫療需求的日益成長。 CRISPR等技術正在革新基因改造的可能性，為遺傳性疾病和慢性疾病的治療方法提供了潛在方案。遺傳性疾病盛行率的上升以及人們對個人化醫療日益成長的興趣是推動市場擴張的主要因素。此外，生物技術研究投入的增加也促進了基因編輯技術的創新。

基因編輯技術在醫療保健、農業和科學研究領域的應用日益廣泛，是推動成長要素。其開發標靶治療和提高作物產量的能力正吸引著各行各業的廣泛關注。生物技術公司與研究機構之間的合作正在加速技術進步。此外，政府對基因研究的支持政策和資金投入也促進了市場成長。

基因編輯市場預計未來將顯著成長，這主要得益於技術的不斷進步和應用領域的不斷拓展。更安全、更精準的編輯技術的發展將促進其在臨床環境中的應用。在新興市場，對生物技術和醫療基礎設施投資的增加可能會創造新的成長機會。此外，持續的研發工作也將繼續探索疾病治療和基因改造領域的新可能性。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球基因編輯市場：依技術分類

• 市場分析、洞察與預測
• CRISPR
• TALEN
• ZFN
• 其他

第5章：全球基因編輯市場：依應用領域分類

• 市場分析、洞察與預測
• 生物醫學
• 農業
• 產業
• 其他

第6章 全球基因編輯市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 學術研究機構
• 臨床研究機構
• 其他

第7章 全球基因編輯市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • CRISPR Therapeutics
  • Editas Medicine
  • Intellia Therapeutics
  • Sangamo Therapeutics
  • Beam Therapeutics
  • Precision BioSciences
  • Caribou Biosciences
  • Cellectis
  • Horizon Discovery Group
  • Bluebird Bio
  • Recombinetics
  • Inscripta
  • Synthego
  • Genscript Biotech
  • Origene Technologies

The Gene Editing Market size is expected to reach USD 29.51 Billion in 2034 from USD 7.80 Billion (2025) growing at a CAGR of 15.93% during 2026-2034.

The global gene editing market is witnessing rapid growth driven by advancements in genetic engineering and increasing demand for precision medicine. Technologies such as CRISPR are revolutionizing the ability to modify genes, offering potential treatments for genetic disorders and chronic diseases. The rising prevalence of genetic conditions and the growing focus on personalized healthcare are key factors driving market expansion. Additionally, increasing investments in biotechnology research are supporting innovation in gene editing technologies.

Key growth drivers include the expanding applications of gene editing in healthcare, agriculture, and research. The ability to develop targeted therapies and improve crop yields is attracting significant attention from various industries. Collaborations between biotechnology companies and research institutions are accelerating technological advancements. Furthermore, supportive government policies and funding for genetic research are contributing to market growth.

In the future, the gene editing market is expected to grow significantly with continuous advancements in technology and expanding application areas. The development of safer and more precise editing techniques will enhance clinical adoption. Emerging markets are likely to offer new growth opportunities due to increasing investments in biotechnology and healthcare infrastructure. Additionally, ongoing research will continue to unlock new possibilities in disease treatment and genetic modification.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• CRISPR
• TALEN
• ZFN
• Others

By Application

• Biomedical
• Agriculture
• Industrial
• Others

By End-User

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Clinical Research Organizations
• Others

COMPANIES PROFILED

• CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Sangamo Therapeutics, Beam Therapeutics, Precision BioSciences, Caribou Biosciences, Cellectis, Horizon Discovery Group, Bluebird Bio, Recombinetics, Inscripta, Synthego, Genscript Biotech, Origene Technologies
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENE EDITING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. CRISPR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. TALEN Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. ZFN Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENE EDITING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Biomedical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Agriculture Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Industrial Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENE EDITING MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Clinical Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENE EDITING MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Technology
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Technology
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Technology
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Technology
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Technology
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL GENE EDITING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 CRISPR Therapeutics
  • 9.2.2 Editas Medicine
  • 9.2.3 Intellia Therapeutics
  • 9.2.4 Sangamo Therapeutics
  • 9.2.5 Beam Therapeutics
  • 9.2.6 Precision BioSciences
  • 9.2.7 Caribou Biosciences
  • 9.2.8 Cellectis
  • 9.2.9 Horizon Discovery Group
  • 9.2.10 Bluebird Bio
  • 9.2.11 Recombinetics
  • 9.2.12 Inscripta
  • 9.2.13 Synthego
  • 9.2.14 Genscript Biotech
  • 9.2.15 Origene Technologies